Adaptive Virotherapy Strategy for Organism with Constrained Input Using Medicine Dosage Regulation Mechanism

Author:

Sun Jiayue,Xu Shun,Liu Yang,Zhang Huaguang

Abstract

AbstractIn this chapter, the constrained adaptive control strategy based on virotherapy is investigated for organism using the medicine dosage regulation mechanism (MDRM). Firstly, the tumor-virus-immune interaction dynamics is established to model the relations among the tumor cells (TCs), virus particles and the immune response. ADP method is extended to approximately obtain the optimal strategy for the interaction system to reduce the populations of TCs. Due to the consideration of asymmetric control constraints, the non-quadratic functions are proposed to formulate the value function such that the corresponding Hamilton-Jacobi-Bellman equation (HJBE) is derived which can be deemed as the cornerstone of ADP algorithms. Then, the ADP method of single-critic network architecture which integrates MDRM is proposed to obtain the approximate solutions of HJBE and eventually derive the optimal strategy. The design of MDRM makes it possible for the dosage of the agentia containing oncolytic virus particles to be regulated timely and necessarily. Furthermore, the uniform ultimate boundedness of the system states and critic weight estimation errors are validated by Lyapunov stability analysis. Finally, simulation results are given to show the effectiveness of the derived therapeutic strategy.

Publisher

Springer Nature Singapore

Reference41 articles.

1. Andtbacka RH, Kaufman HL, ..., Coffin RS (2015) Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol 33(25):2780–2788

2. Wodarz D (2001) Viruses as antitumor weapons: defining conditions for tumor remission. Can Res 61(8):3501–3507

3. Wu JT, Byrne HM, Kirn DH, Wein LM (2001) Modeling and analysis of a virus that replicates selectively in tumor cells. Bull Math Biol 63(4):731–768

4. Wein LM, Wu JT, Kirn DH (2003) Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: Implications for virus design and delivery. Can Res 63(6):1317–1324

5. Wodarz D (2003) Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agents. Hum Gene Ther 14(2):153–159

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3